GlassScriptPhysician profile
Alan A Saber
NPI 1861461113
$204,457.23
in general payments reported to CMS, 2019-2025
24 companies · $19K in 2025
The $19K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $31K · 2021: $5,845 · 2022: $59K · 2023: $29K · 2024: $43K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $64K · Travel and Lodging: $9,626 · Food and Beverage: $6,922 · Education: $5,566 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,550 · Honoraria: $500 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $63,742.50 |
| Travel and Lodging | $9,625.77 |
| Food and Beverage | $6,921.90 |
| Education | $5,566.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,550.00 |
| Honoraria | $500.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $140,491.30 | 2019-2025 | Tisseel, Peri-Strips Dry, Floseal |
| Covidien LP | $22,318.69 | 2019-2020 | |
| Medtronic, INC. | $16,792.18 | 2021-2025 | Ligasure, Endoflip |
| Intuitive Surgical, INC. | $9,899.34 | 2019-2025 | Da Vinci Surgical System |
| Stryker Corporation | $3,061.31 | 2020-2023 | 1688 |
| Heron Therapeutics, INC. | $2,312.98 | 2022 | |
| Davol INC. | $1,974.39 | 2023-2025 | Arista Ah Flexitip |
| Tela Bio, INC. | $1,778.90 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Endolumik, INC. | $1,600.00 | 2024 | Endolumik Gastric Calibration Tube |
| W. L. Gore & Associates, INC. | $850.88 | 2020-2024 | Gore Synecor Biomaterial |
| Intra-Sana Laboratories | $762.90 | 2022-2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Standard Bariatrics, INC. | $601.88 | 2020-2022 | |
| Novo Nordisk INC | $540.00 | 2022-2025 | Wegovy |
| Next Science LLC | $317.78 | 2021-2023 | Blastx, Xperience, Surgx |
| Hologic Sales and Service, LLC | $291.97 | 2025 | Coolseal Generator |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $253.20 | 2019-2020 | |
| Suture Ease, INC. | $186.36 | 2024 | |
| Medical Device Business Services, INC. | $113.24 | 2019 | |
| Karl Storz Endoscopy-America | $105.95 | 2022 | |
| Ethicon US, LLC | $93.60 | 2019 | |
| Conmed Corporation | $55.56 | 2019 | |
| Olympus America INC. | $19.87 | 2021 | |
| Organogenesis INC. | $19.55 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Saber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.